Cell BioEngines

Cell BioEngines is a clinical-stage biotechnology company pioneering off-the-shelf, allogeneic cell therapies for oncology and regenerative medicine. Founded in December 2022, the company's proprietary STEM-Space™ platform enables transgene-free chemical reprogramming of stem cells without genetic engineering, combined with HLA-guided design and a population-informed biobank to achieve broad patient coverage. Unlike autologous therapies that require patient-specific manufacturing, Cell BioEngines' approach enables scalable, low-cost production of standardized cell-based therapeutics that can be stockpiled and distributed like conventional drugs.